Diamond Biotechnology Past Earnings Performance
Past criteria checks 2/6
Diamond Biotechnology has been growing earnings at an average annual rate of 11.5%, while the Medical Equipment industry saw earnings growing at 11.4% annually. Revenues have been growing at an average rate of 21.1% per year. Diamond Biotechnology's return on equity is 13.9%, and it has net margins of 8.5%.
Key information
11.5%
Earnings growth rate
1.9%
EPS growth rate
| Medical Equipment Industry Growth | 11.5% |
| Revenue growth rate | 21.1% |
| Return on equity | 13.9% |
| Net Margin | 8.5% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Diamond Biotechnology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 538 | 46 | 142 | 25 |
| 31 Mar 23 | 487 | 40 | 127 | 25 |
| 31 Dec 22 | 435 | 33 | 112 | 26 |
| 30 Sep 22 | 435 | 48 | 107 | 28 |
| 30 Jun 22 | 435 | 64 | 102 | 31 |
| 31 Mar 22 | 415 | 53 | 107 | 29 |
| 31 Dec 21 | 395 | 42 | 112 | 28 |
| 30 Sep 21 | 353 | 19 | 118 | 20 |
| 30 Jun 21 | 311 | -4 | 123 | 12 |
| 31 Mar 21 | 309 | 3 | 117 | 7 |
| 31 Dec 20 | 306 | 11 | 111 | 3 |
| 30 Sep 20 | 295 | 20 | 102 | 3 |
| 30 Jun 20 | 283 | 29 | 94 | 2 |
| 31 Mar 20 | 276 | 37 | 86 | 2 |
| 31 Dec 19 | 268 | 44 | 77 | 1 |
| 31 Dec 18 | 228 | 41 | 49 | 4 |
| 31 Dec 17 | 193 | 42 | 42 | 0 |
Quality Earnings: 6815 has high quality earnings.
Growing Profit Margin: 6815's current net profit margins (8.5%) are lower than last year (14.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6815's earnings have grown by 11.5% per year over the past 5 years.
Accelerating Growth: 6815's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 6815 had negative earnings growth (-27.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (-17.2%).
Return on Equity
High ROE: 6815's Return on Equity (13.9%) is considered low.